Researchers from the Texas A&M University System Health Science Center College of Medicine have found significant price differences and differences in price increases for glaucoma treatments in a new study.

University of Arizona engineers have developed a self-administered test that may revolutionize glaucoma treatment.

Researchers at Duke University Medical Center have helped uncover a gene associated with nearsightedness (myopia) in Caucasians from different regions.

Resveratrol may help halt uncontrolled blood vessel growth in the eye, pointing the way to better therapies for conditions such as diabetic retinopathy and age-related macular degeneration (AMD).

Glaucoma, a leading cause of blindness in the U.S., may not start in the optic nerve of the eye as previously believed. Researchers indicate the first sign of the disease may appear in the brain.

Researchers from the Kennedy Krieger Institute and four collaborating institutions have identified an unexpected biological pathway that may contribute to glaucoma.